Kingella kingae infections in children by N. Principi & S. Esposito
REVIEW Open Access
Kingella kingae infections in children
Nicola Principi and Susanna Esposito*
Abstract
Background: Improvements in culture techniques and molecular detection methods have led to findings
indicating that, particularly in infants and young children, Kingella kingae is a significantly more important pathogen
than previously thought. However, despite this, the pediatric community is still largely unaware of the existence of
this organism. The aim of this review is therefore to summarise current knowledge of the epidemiology,
transmission, clinical presentation, diagnosis and treatment of K. kingae infections in children.
Discussion: K. kingae is a common coloniser of the oropharynx, can be transmitted from child to child, and can
cause outbreaks of infection. Invasive infections almost exclusively occur in children aged between six months and
four years of age, and involve mainly joints and bone, less frequently the endocardium, and very rarely other
localisations. With the exception of bacteremia and endocarditis, which can be followed by severe complications,
the diseases due to K. kingae are usually accompanied by mild to moderate clinical signs and symptoms, and only
slightly altered laboratory data. Moreover, they generally respond to widely used antibiotics, although resistant
strains are reported. However, the mild symptoms and limited increase in the levels of acute phase reactants create
problems because K. kingae disease may be confused with other clinical conditions that have a similar clinical
picture.
Conclusions: Although K. kingae was identified more than 50 years ago, it is poorly known by pediatricians and is
not systematically sought in laboratories. Education is therefore necessary in order to reduce the risk of outbreaks,
permit the early identification of K. kingae infections, and allow the prompt prescription of adequate therapeutic
regimens capable of avoiding the risk of a negative evolution in those cases in which this elusive pathogen can
cause significant clinical problems.
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Background
For most of the three decades following its first descrip-
tion in 1960, Kingella kingae was considered as a rare
cause of human disease that was only infrequently iso-
lated from patients with skeletal infections and endocar-
ditis [1]. However, since the early 1990s, improvements
in culture techniques and molecular detection methods,
together with the increasing familiarity of clinical micro-
biology laboratories with its identification, have shown
that it is significantly more important than previously
thought, particularly in infants and young children [1]. It
is now recognised as a frequent cause of bacteremia and
osteoarticular infections in children aged less than four
years [2, 3], and has been associated with some cases of
rapidly progressive, complicated endocarditis [4] and, al-
beit rarely, cases of pneumonia, meningitis, ocular infec-
tions, pericarditis and peritonitis [5–9]. There are also
reports of outbreaks of K. kingae infections in day care
facilities [1].
However, despite this, the pediatric community is still
largely unaware of the existence of this organism. The
aim of this review is therefore to summarise current
knowledge of the epidemiology, transmission, clinical
presentation, diagnosis and treatment of K. kingae infec-
tions in children. PubMed was used to search for all of
the studies published over the last 15 years using the key
words: “Kingella kingae” and “children” or “pediatric”.
More than 200 articles were found, but only those pub-
lished in English or providing evidence-based data were
included in the evaluation.
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Discussion
The pathogen and its identification
K. kingae is a facultative anaerobic, β-hemolytic, Gram-
negative organism [1] that is difficult to identify in rou-
tine solid cultures of blood or body fluids such as syn-
ovial fluid or bone exudates as it is isolated in less than
10 % of truly positive cases. However, significantly more
cases have been reported when exudates are inoculated
into aerobic blood culture vials, particularly when the
positive samples are sub-cultured on a blood-agar plate
of trypticase soy agar with 5 % sheep blood hemoglobin
or chocolate agar. This need for specific culture tech-
niques explains why the etiology of a number of invasive
diseases due to K. kingae (particularly septic arthritis and
osteomyelitis in young children) was not initially identi-
fied, thus leading to the definition of “culture-negative
bone infections of unknown origin” [1].
It is even more difficult to identify K. kingae in cul-
tured pharyngeal samples because of its relatively slow
growth and the high density of resident bacterial flora,
although this can be overcome by using a selective
medium consisting of blood-agar with added vanco-
mycin to inhibit the growth of competing flora [1].
The best means of detecting K. kingae are the recently
developed nucleic acid amplification assays because they
are not only significantly more sensitive than culture,
but also reduce the time needed for bacterial identifica-
tion from 3–4 days to a few hours. They also make it
possible to use pharyngeal secretions to diagnose inva-
sive K. kingae invasive infections, as described by Ceroni
et al. who used a polymerase chain reaction (PCR) to
identify the etiology of a K. kingae osteoarticular infec-
tion from pharyngeal swabs [10]. They found that the
method was 100 % sensitive and 90.5 % specific, thus
making a negative swab sufficient to rule out K. kingae
infection and prompt more invasive diagnostic measures.
However, K. kingae detection in the oropharynx of a
child with an osteoarticular infection is not an irrefut-
able proof of the etiology of the disease because the car-
riage rate of the organism among pediatric patients is
around 10-12 % [1].
Furthermore, the molecular typing of isolates has re-
vealed genomic heterogeneity in K. kingae species, and
made it possible to study the possible association be-
tween the genetic characteristics of the different strains
and their tendency to cause invasive disease, as well as
the relationships between antibiotic resistance and geno-
type distribution. One of the most widely used molecular
techniques is the amplification and sequencing of poly-
morphisms of the rtxA gene, which is involved in the
production of a protein belonging to the RTX toxin fam-
ily that has been associated with the virulence of K.
kingae insofar as disruption of the RTX locus leads to
the loss of cytotoxicity for respiratory epithelial, synovial,
and macrophage cell lines [11]. Furthermore, when
Chang et al. [12] infected rats with K. kingae strain
PYKK081 and its isogenic rtxA-deficient strain
KKNB100, they found that PYKK081 causing a fatal ill-
ness characterised by rapid weight loss, bacteremia, the
formation of necrotic abdominal lesions, and significant
histopathology in thymus, spleen and bone marrow,
whereas KKNB100 was less toxic and did not induce
weight loss, bacteremia or histopathological changes. In
addition, the animals injected with KKNB100 had sig-
nificantly high circulating white blood cell (WBC)
counts, whereas the counts of the rats injected with
PYKK081 were similar to those recorded in the unin-
fected controls [12].
The use of pulsed-field electrophoresis (PFGE) has
made it possible to establish that a number of the K.
kingae clones that are relatively frequently isolated
asymptomatic carriers (A, C, G, J, M, R, T and U) play a
marginal role in determining invasive infections, whereas
clones B, H, K, N and P are significantly more frequently
associated with the development of disease [13]. This
suggests that the more invasive strains may be more rap-
idly cleared from the respiratory tract and that their per-
sistence may require a different biological specialisation.
It was also found that each of the virulent clones may
be responsible for a well-defined disease as clone K
was significantly associated with bacteremia, clone N
with skeletal system infections, and clone P with bac-
terial endocarditis [13].
It was initially shown that K. kingae isolates were al-
most always susceptible to most of the antibiotics that
are routinely administered to children with suspected
bacteremia or skeletal system infections, including penicil-
lin, ampicillin, second- and third-generation cephalospo-
rins, macrolides, rifampin, co-trimoxazole, ciprofloxacin,
tetracycline and chloramphenicol, whereas oxacillin, clin-
damycin and daptomycin were not very effective, and tri-
methoprim and glycopeptide antibiotics had no activity at
all [14]. However, resistance of K. kingae to β-lactam anti-
biotics has more recently been repeatedly reported, al-
though the rates vary widely from one country to another:
Basmaci et al. screened 778 isolates from Iceland, the
USA, France, Israel, Spain and Canada for β-lactamase
production, and found that the French, Spanish and
Canadian isolates were negative, whereas 28.6 % of the
Icelandic, 25.0 % of the American, and 11 % of the Israeli
isolates were positive [15]. The distribution of β-lactam
antibiotic resistance among invasive and carried organ-
isms has not yet been precisely defined, but Yagupsky
et al. found enzyme production in 1.1 % of the invasive or-
ganisms and 15.4 % of the carried organisms detected in a
sample of 619K. kingae isolates from Israel [16]. This find-
ing seemed to be confirmed by the PFGE studies of the
genotypic clonality of the strains because β-lactamase
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production was limited to only four of the 73 identified
clones (33 in invasive and 56 in carriage isolates), and
these four were common among the carried strains but
rare among the invasive strains [16]. However, Basmaci
et al. found that all of their American and Icelandic β-
lactamase-positive isolates belonged to the main inter-
national invasive PFGE clone K/MLST ST-6, and were
different from the four genetically unrelated Israeli β-
lactamase-producing clones [15]. The presence of the
enzyme in the isolates belonging to the major world-
wide invasive K. kingae clone highlights the possible
spread of β-lactam resistance, and emphasises the im-
portance of routinely testing all K. kingae clinical iso-
lates for β-lactamase production.
Carriage and transmission
Asymptomatic colonisation of the upper respiratory tract
by K. kingae is extremely common in children, who ac-
quire the infectious agent after six months of life [1];
subsequently, the incidence of colonization tends to de-
crease to 10-12 % until the end of the second year before
gradually declining to very low levels in older children
and adults (Table 1). This suggests that the disappear-
ance of vertically transmitted immunity and the greater
socialisation of children aged more than six months in-
crease the risk of colonisation, whereas progressive im-
munological maturation and/or accumulative familiarity
with K. kingae antigens as a result of mucosal colonisa-
tion lead to the acquisition of sufficient immunity to
eradicate the organism from the pharynx in older
people. This seems to be confirmed by the results of a
study designed to evaluate the dynamics of K. kingae
antibody levels in childhood, which showed that mean
IgG level is high at the age of two months, gradually de-
creases until the age of 6–7 months (the time of lowest
concentrations), remains low until the age of 18 months,
and subsequently increases [17].
Carriage may be continuous for weeks or months, or
intermittent as shown by the findings of an 11-month
longitudinal study of children aged 19–48 months old
attending a day care centre in Israel [18]: about 73 %
carried the organism at least once and half carried it for
at least two months during the follow-up period. More-
over, colonisation was greatest during late winter and
spring, and characteristically involved oropharynx be-
cause K. kingae was hardly ever found in the nasophar-
ynx [18].
Colonised children are the main cause of the spread of
the pathogen. This was suggested by the fact that colon-
isation rates are significantly higher in children attending
day care centres than in the general population of the
same age, and was confirmed by a comparative genetic
analysis of cultured K. kingae isolated from colonised
children and their siblings and playmates that clearly re-
vealed the indistinguishable genotype profiles of the
strains identified in both groups [19]. Moreover, al-
though it is asymptomatic in the great majority of chil-
dren, colonisation is a prerequisite for the development
of disease, and genotypically identical isolates have been
recovered from the pharynx and bloodstream of patients
with invasive K. kingae infections [20]. On the basis of
these findings, it is not surprising that a number of out-
breaks of K. kingae disease have been associated with
day care centres [3, 21, 22]: in all of these cases, unusually
high K. kingae colonisation rates were found among the
asymptomatic attendees, and all the pharyngeal isolates
detected in the classrooms were genetically identical to
those identified in patients [9].
Clinical manifestations
The pathogenesis of invasive K. kingae infection has not
yet been defined, but some data seem to indicate that its
penetration is favoured by a concomitant viral infection
capable of damaging oropharyngeal mucosa. Stomatitis
and symptoms of respiratory infection are common in
patients with K. ingaek disease [23]. The pathogen was
isolated from the blood of four out of 29 patients with
primary herpetic gingivostomatitis [24], and it has been
suggested that, after penetration, it can progress to the
lower respiratory tract or invade the bloodstream and
subsequently reach the skeletal system, heart or other
parts of the body [18].
Invasive infectious K. kingae disease generally develops
in younger and otherwise healthy children, and its age
distribution is similar to that of carriage. Almost 90 % of
the reported cases have occurred in children aged
<5 years, and 60 % in those aged <2 years [18]. As in the
case of invasive Streptococcus pneumoniae and Neisseria
meningitidis infections [25, 26], invasive K. kingae infec-
tions are more common in males [2].
In most cases, K. kingae bacteremia is detected con-
comitantly with infections of the skeletal, cardiovascular,
respiratory or central nervous systems; however, occult
bacteremia has been diagnosed in a number of cases,
some of which were characterised by a maculopapular
rash resembling those seen in patients with disseminated
meningococcal disease [27]. The fact that K. kingae is
identified in the blood of very few patients with
Table 1 Kingella kingae carriage
Characteristic Finding
Main interested population Young children attending day-care
Seasonality Mainly detected in late winter and spring
Risk factor Great socialisation
Protective factor Immunological maturation
Site of colonisation Oropharynx
Role of colonisation Prerequisite for the development of disease
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ascertained invasive infection even when sensitive and
specific molecular methods are used suggests that the
duration of bacteremia is usually short [27].
The most frequent clinical manifestation of invasive K.
kingae infection are osteoarticular infections [1], and K.
kingae is the most common cause of such infections in
children aged between six months and four years [28]:
one recent molecular study by Ceroni et al. found that
82 % of the joint or bone aspirates of children aged
<4 years with osteoarticular infection were positive [29].
Unlike the joint or bone infections due to other bacterial
pathogens (mainly Staphylococcus aureus), which usually
have a severe clinical picture, osteoarticular K. kingae in-
fections are generally characterised by mild to moderate
clinical and radiological manifestations, and a limited
biological inflammatory response [1, 2, 28, 29]. Ceroni
et al. observed that fewer than 15 % of their children
were febrile, 39 % had normal C-reactive protein (CRP)
levels, and only 9 % had high WBC counts [29];
Dubnoz-Raz et al. found fever in 25 % of their patients,
a WBC count of >15,000/mm3 in only about 50 %, and
CRP levels within the normal range in 22 % [2]. These
findings led to the development of an algorithm for the
reliable prediction of the K. kingae etiology of an
osteoarticular disease in younger children that includes a
body temperature of <38 °C, CRP levels of <55 mg/L, a
WBC count of <14,000/mm3, and bands of <150/mm3
[30]. However, the possibility to predict osteoarticular
K. kingae infections on the bases of mild clinical symp-
toms and acute phase reactants is disputed and still
controversial.
Septic arthritis is mainly diagnosed in the large
weight-bearing joints, with synovial fluid WBC counts of
<50,000/mm3 in about 25 % of patients, thus underlining
their poor inflammatory response [18]. However, the
limited clinical evidence of septic arthritis due to K.
kingae can prevent a prompt diagnosis in certain cases,
thus leading to an increased risk of greater morbidity
due to delayed treatment. K. kingae septic arthritis of the
hip is a good example because it may be impossible to
differentiate it from transient synovitis on purely clinical
grounds. In an attempt to improve the identification of
septic arthritis of the hip, Kocher et al. developed a
specific algorithm based on clinical variables (body
temperature upon admission and a refusal to bear
weight) and laboratory data (WBC counts and the
erythrocyte sedimentation rate [ESR]) that allows the
probable exclusion of septic arthritis when WBC counts
and the ESR are within the normal range, there is little or
no fever, and there are no demonstrable weight bearing
problems [31]. However, although the algorithm may be
valid in the case of septic arthritis due to other bacteria
[32], it cannot be used in the case of K. kingae disease in
which all or some of the variables overlap those found in
transient synovitis and variation between laboratories may
influence the results [33]. Osteomyelitis mainly involves
the long bones but also frequently affects bones that are
not usually infected by other organisms, such as the calca-
neus, talus, sternum and clavicle [34–36].
Spondylodiscitis is another quite frequent clinical
manifestation of K. kingae infection [1]. Like osteomye-
litis and septic arthritis, spondylodiscitis due to K. kingae
is mainly diagnosed in children aged between six months
and four years [37]. The lumbar intervertebral spaces are
most frequently affected by mild to moderate signs and
symptoms.
Endocarditis is the most severe manifestation of K.
kingae infection. It usually occurs in children who are a
little older than those suffering from osteoarticular infec-
tions and, unlike osteomyelitis and septic arthritis, is ac-
companied by a high fever and a significant increase in
the levels of acute phase reactants [4]. As of July 2014, a
total of 42 patients with K. kingae endocarditis had been
described in the literature [4], at least 20 % of whom
were aged >4 years. At the time of presentation, most of
the patients had a body temperature of >39 °C, and
mean ESR and CRP levels were respectively 60.4 mm/h
and 12.5 mg/dL. Valvular disease was relatively frequent,
particularly in the older children, although only a minor-
ity had previously been diagnosed as having congenital
heart disease. However, the most serious problem asso-
ciated with K. kingae endocarditis is the emergence of
embolic complications that can lead to severe neuro-
logical consequences, which have occurred in 13 of the
42 described cases: the most frequent are stroke (77 %)
and meningitis (46 %), which have led to the death of
four patients (10 %) [4]. Other complications of K.
kingae endocarditis include valvular insufficiency, car-
diogenic shock, pulmonary infarction and paravalvular
abscesses [4].
Other infections such those involving the lower re-
spiratory tract, the central nervous system and the eye
are rare [5–8]. In particular, meningitis seems to be dif-
ferent from the more common K. kingae infections be-
cause instead of being diagnosed in younger children, it
has mainly occurred in adolescents [5, 38].
Table 2 summarizes the main clinical presentations.
Prognosis and treatment
Most K. kingae infections are susceptible to the majority
of the oral and parenteral antibiotics usually prescribed
for young febrile children and, although some invasive
β-lactamase-producing strains are resistant to β-lactam
antibiotics and require appropriate monitoring, they do
not seem to condition the final prognosis of K. kingae
invasive diseases. Consequently, although no compara-
tive controlled study has been published and it is not
possible to establish the best antibiotic approach, most
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invasive diseases due to K. kingae have a benign clinical
course when adequately diagnosed. However, diagnostic
delays and hospital admission are very common. Skeletal
infections generally recover without sequelae provided
that they are immediately and appropriately treated in-
cluding spondylodiscitis, although persistent narrowing
of the intervertebral space may remain [39]. The only
exception is endocarditis, mainly because of its embolic
complications, the most common of which is cerebral
infarction [4]. Therefore, when the diagnosis of K. kingae
endocarditis is suspected or ascertained, health author-
ities recommend the prompt use of appropriate labora-
tory methods in order to get information concerning
antimicrobial susceptibility as quickly as possible [40].
According to the clinical presentation, the first line ther-
apy usually used for osteomyelitis, septic arthritis or
endocarditis can be recommended and then, if K. kingae
etiology will be confirmed, antimicrobial therapy can be
optimized according to the results of the antimicrobial
susceptibility test if available or using a second- or third-
generation cephalosporin.
A still unsolved problem is how to manage outbreaks
of K. kingae infection, but it has been suggested that
prophylactic antibacterial drugs can be administered to
prevent further cases of disease. As it has been found
that rifampin, which is particularly active against K.
kingae, is secreted in saliva and reaches high concentra-
tions in the upper respiratory tract mucosa, and has
been effective in eradicating other invasive pharyngeal
colonisers such as Haemophilus influenzae type b and
Neisseria meningitidis, it has been suggested that it
should be given at a dose of 10 mg/kg twice daily for
two days, alone or in combination with amoxicillin
80 mg/kg/day for two or four days [1, 21]. However, the
systematic use of rifampin prophylaxis remains a subject
of debate because the results have not always been satis-
factory as eradication of K. kingae was achieved in only
some of the treated children or new colonisation by the
same strain was observed some weeks later [22]. This
was not because of bacterial resistance, but appeared at
least partially due to poor compliance. Furthermore, the
use of antibiotic prophylaxis is supported by the fact that
no further cases of invasive K. kingae disease were diag-
nosed in the affected day care centres even when a few
children continue to be colonised by the invasive K.
kingae strain [22]. Nevertheless, detecting an outbreak of
K. kingae infection is still difficult, mainly because of the
low rate of K. kingae testing. It has been suggested that
an algorithm for investigating and managing clusters of
invasive K. kingae infections in day care centres would
be useful [9], but the many controversial areas of inter-
vention and the inclusion of genetic analyses to guide
management make its use particularly difficult in geo-
graphic areas where appropriate laboratory facilities are
not available.
Conclusions
Modern laboratory techniques have led to the identifica-
tion of K. kingae as a significantly more important infec-
tious agent than previously thought. It is a common
coloniser of the oropharynx, can be transmitted from
child to child, and can cause outbreaks in day care facil-
ities. Invasive infections almost exclusively occur in chil-
dren aged between six months and four years, and
mainly involve joints and bone, less frequently the endo-
cardium, and very rarely other localisations. With the
exception of endocarditis, which can be followed by se-
vere complications, the diseases due to K. kingae are
usually accompanied by mild to moderate clinical signs
and symptoms, and only slightly altered laboratory data.
Moreover, they generally respond to widely used antibi-
otics, although resistant strains are reported. However,
the mild symptoms and limited increase in the levels of
acute phase reactants create problems because K. kingae
disease may be confused with other clinical conditions
that have a similar clinical picture.
It is for these reasons that, although K. kingae was
identified more than 50 years ago, it is poorly known by
Table 2 Main clinical presentations of Kingella kingae infection
Clinical presentation Characteristic
Occult bacteremia Mainly in children aged <5 years, more common in males, sometimes with a maculopapular rash
Osteoarticular infection Generally characterised by mild to moderate clinical and radiological manifestations, limited inflammatory response,
mainly in the long bones or in bones that are not infected by other organisms (i.e., calcaneus, talus, sternum, and
clavicle)
Septic arthritis Mainly in the large weight-hearing joints, limited clinical evidence, limited inflammatory response
Spondylodiscitis Mainly in children aged <5 years,, mild to moderate signs in the lumbar intervertebral spaces
Endocarditis Most severe manifestation of K. kingae infection, characterised by fever >39 °C and increased inflammatory markers,
possibility of embolic complications with severe neurologic consequences as well as valvular insufficiency, cardiogenic
shock, pulmonary infarction and paravalvular abscesses
Meningitis Mainly in adolescents
Lower respiratory tract
infection
Rare
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pediatricians and is not systematically sought in la-
boratories. Education is therefore necessary in order to
reduce the risk of outbreaks, permit the early identifi-
cation of K. kingae infections, and allow the prompt
prescription of adequate therapeutic regimens capable
of avoiding the risk of a negative evolution in those
cases in which this elusive pathogen can cause signifi-
cant clinical problems.
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